The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα

Table 1

Echocardiographic and hemodynamic data measured 1 week after AB before the start of zileuton treatment.

	Vehicle-AB ()	Zileuton-AB ()
LVEDD (mm)
LVESD (mm)
LVEF (%)
LVFS (%)
ESD (mmHg)
EDD (mmHg)
dp/dt max (mmHg/s)
dp/dt min (mmHg/s)